Overview
CNTB market data
Price History
CNTB price chart
Valuation & Profitability
No Valuation Data Yet
Alpha Vantage and Twelve Data both returned no valuation metrics for CNTB. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.
Company news
Oppenheimer Initiates Coverage On Connect Biopharma Hldgs with Outperform Rating, Announces Price Target of $8Benzinga · Jul 9, 2026, 1:40 PM
Piper Sandler Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $7Benzinga · Jun 26, 2026, 1:50 PM
HC Wainwright & Co. Reiterates Buy on Connect Biopharma Hldgs, Maintains $7 Price TargetBenzinga · Jun 25, 2026, 12:55 PM
Connect Biopharma Completes Enrollment In Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart As Adjunct To Standard Of Care For Acute Exacerbations In Asthma And Type 2 InflammationBenzinga · Jun 17, 2026, 1:10 PM
This Lear Analyst Turns Bullish; Here Are Top 4 Upgrades For TuesdayBenzinga · May 26, 2026, 4:12 PM
This Avalyn Pharma Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For TuesdayBenzinga · May 26, 2026, 12:56 PM
Canaccord Genuity Initiates Coverage On Connect Biopharma Hldgs with Buy Rating, Announces Price Target of $6Benzinga · May 26, 2026, 12:32 PM
Cantor Fitzgerald Initiates Coverage On Connect Biopharma Hldgs with Overweight Rating, Announces Price Target of $4Benzinga · May 21, 2026, 2:20 PM
Connect Biopharma Reports First Quarter 2026 Financial Results and Provides Business UpdateGlobenewswire Inc · May 12, 2026, 1:10 PM
8-K filing — Connect Biopharma Holdings Ltd (CNTB)SEC EDGAR · May 12, 2026, 1:02 PM